drugset / Trial / NCT06532318

Comparative Study Between Platelet Rich Plasma and Steroid Injection in Trigger Finger Treatment

NCT06532318

Phase 3 Not yet recruiting 40 enrolled Obafemi Awolowo University Teaching Hospital
RandomizedSingle-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to learn if platelet rich plasma works to treat early stage trigger finger in adults. It will also learn about the safety platelet rich plasma. The main questions it aims to answer are: Does platelet rich plasma lower the pain associated with trigger finger of participants? Does it improve the hand grip strength and Q DASH score of participants? Researchers will compare platelet rich plasma to Depo-Medrol steroid (a known standard of care for early stage trigger finger) to see if platelet rich plasma works to treat early trigger finger. Participants will: Take platelet rich plasma or a depo-medrol steroid intralesional injection at recruitment into the intervention Visit the clinic once every 4 weeks for checkups and parameter measurements. Investigator will will keep a record of participants progress in symptom remission

Timeline

Start
2024-07-24
Primary completion
2024-12-23
Completion
2025-06-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified 20 mg Other
Subject Platelet Rich Plasma Other / unclassified 1 ml Other